Radius Health Inc.. (RDUS) NASDAQ

$10.08 0 (0.00%)

Market Cap: $0

As of 08/12/22 12:00 AM EDT. Market open.

(RDUS)

Radius Health Inc.. (RDUS) NASDAQ

$10.08 0 (0.00%)

Market Cap: $0

As of 08/12/22 12:00 AM EDT. Market open.

Radius Health Inc. is a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine and other therapeutics. Radius' lead product, TYMLOS® (abaloparatide) injection, was approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The Radius clinical ... read more

Radius Health Inc. is a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine and other therapeutics. Radius' lead product, TYMLOS® (abaloparatide) injection, was approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The Radius clinical pipeline includes investigational abaloparatide injection for potential use in the treatment of men with osteoporosis; an investigational abaloparatide transdermal system for potential use in the treatment of postmenopausal women with osteoporosis; the investigational drug, elacestrant (RAD1901), for potential use in the treatment of hormone-receptor positive breast cancer out-licensed to Menarini Group; and the investigational drug RAD011, a synthetic cannabidiol oral solution with potential utilization in multiple endocrine and metabolic orphan diseases, initially targeting Prader-Willi syndrome. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
G. Kelly Martin
Full Time Employees
310
CEO Compensation (Base)
$624,000
CEO Compensation (Total)
$5.43M
URL
Address
950 Winter St, Massachusetts, Waltham, 02451-1424.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
G. Kelly Martin
Full Time Employees
310
CEO Compensation (Base)
$624,000
CEO Compensation (Total)
$5.43M
Address
950 Winter St, Massachusetts, Waltham, 02451-1424.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$0
Previous Close
$10.08
Days Range
$10.06 - $10.18
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
47,620,498
Open
$0
Previous Close
$10.08
Days Range
$10.06 - $10.18
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
47,620,498

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR RADIUS HEALTH INC.
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
BIOTECH TARGET N V 10% Owner Aug 11, 2022 Option Exercise $10.00 8,733,538 87,335,380 0 Aug 30, 2022, 12:05 PM
SANDERS MACHELLE Director Aug 15, 2022 Option Exercise $10.00 5,500 55,000 0 Aug 15, 2022, 04:19 PM
Hughes Owen Director Aug 15, 2022 Option Exercise $10.00 21,650 216,500 0 Aug 15, 2022, 04:19 PM
Shah Chhaya Chief Business Officer Aug 15, 2022 Option Exercise $10.00 94,645 946,450 0 Aug 15, 2022, 04:19 PM
FRIEDMAN CATHY Director Aug 15, 2022 Option Exercise $10.00 26,800 268,000 0 Aug 15, 2022, 04:17 PM
Dere Willard H Director Aug 15, 2022 Option Exercise $10.00 1,895 18,950 0 Aug 15, 2022, 04:16 PM
Dere Willard H Director Aug 15, 2022 Option Exercise $10.00 21,300 213,000 1,895 Aug 15, 2022, 04:16 PM
GARNIER JEAN PIERRE Director Aug 15, 2022 Option Exercise $10.00 5,500 55,000 0 Aug 15, 2022, 04:16 PM
GARNIER JEAN PIERRE Director Aug 15, 2022 Option Exercise $10.00 26,800 268,000 5,500 Aug 15, 2022, 04:16 PM
VON ESCHENBACH ANDREW C. Director Aug 15, 2022 Option Exercise $10.00 5,500 55,000 0 Aug 15, 2022, 04:15 PM
Holtschlag Danielle Vice President, Sales Aug 15, 2022 Option Exercise $10.00 25,000 250,000 0 Aug 15, 2022, 04:14 PM
Messersmith Elizabeth Senior Vice President Aug 15, 2022 Option Exercise $10.00 70,000 700,000 0 Aug 15, 2022, 04:14 PM
Murphy Sean Director Aug 15, 2022 Option Exercise $10.00 5,500 55,000 0 Aug 15, 2022, 04:14 PM
Martin G. Kelly CEO and President Aug 15, 2022 Option Exercise $10.00 75,000 750,000 0 Aug 15, 2022, 04:13 PM
Rubric Capital Management LP 10% Owner Aug 11, 2022 Buy $10.07 1,678,954 16,907,066 8,642,271 Aug 12, 2022, 12:06 PM
Rubric Capital Management LP 10% Owner Aug 10, 2022 Buy $10.07 4,012 40,401 6,963,317 Aug 11, 2022, 10:43 AM
BIOTECH TARGET N V 10% Owner May 18, 2022 Buy $5.57 477,824 2,661,002 8,733,538 May 20, 2022, 11:35 AM
BIOTECH TARGET N V 10% Owner Jan 06, 2022 Buy $6.31 300,000 1,894,410 8,255,714 Jan 07, 2022, 11:33 AM
BIOTECH TARGET N V 10% Owner Jan 05, 2022 Buy $6.30 250,000 1,574,650 7,955,714 Jan 07, 2022, 11:33 AM
Rubric Capital Management LP 10% Owner Dec 16, 2021 Buy $7.07 146,685 1,037,752 6,959,305 Dec 16, 2021, 05:32 PM
Rubric Capital Management LP 10% Owner Dec 15, 2021 Buy $6.77 180,744 1,223,637 6,812,620 Dec 15, 2021, 05:22 PM
Rubric Capital Management LP 10% Owner Dec 14, 2021 Buy $6.81 94,103 640,936 6,631,876 Dec 15, 2021, 05:22 PM
Rubric Capital Management LP 10% Owner Dec 13, 2021 Buy $7.08 187,391 1,326,803 6,537,773 Dec 15, 2021, 05:22 PM
Rubric Capital Management LP 10% Owner Dec 09, 2021 Buy $7.58 264,644 2,007,086 5,582,211 Dec 10, 2021, 06:01 PM
Rubric Capital Management LP 10% Owner Dec 08, 2021 Buy $8.02 560,691 4,497,078 5,317,567 Dec 10, 2021, 06:01 PM
Rubric Capital Management LP 10% Owner Dec 10, 2021 Buy $7.18 768,171 5,511,627 6,350,382 Dec 10, 2021, 06:01 PM
BIOTECH TARGET N V 10% Owner Sep 29, 2021 Buy $12.94 100,000 1,294,500 7,705,714 Oct 01, 2021, 10:34 AM
BIOTECH TARGET N V 10% Owner Sep 22, 2021 Buy $12.28 150,000 1,841,280 7,605,714 Sep 24, 2021, 11:58 AM
Chopas James George Principal Finance Accounting Mar 05, 2021 Sale $20.88 370 7,726 6,701 Mar 09, 2021, 06:54 AM
Grausso Sal Chief Commercial Officer Feb 25, 2021 Sale $18.93 1,322 25,025 11,709 Feb 26, 2021, 04:36 PM
BIOTECH TARGET N V 10% Owner Nov 05, 2020 Buy $14.26 100,000 1,426,230 7,455,714 Nov 09, 2020, 11:29 AM
BIOTECH TARGET N V 10% Owner Sep 14, 2020 Buy $11.69 200,000 2,338,680 7,355,714 Sep 16, 2020, 12:01 PM
BIOTECH TARGET N V 10% Owner Sep 11, 2020 Buy $11.33 199,029 2,255,118 7,155,714 Sep 14, 2020, 04:03 PM
BIOTECH TARGET N V 10% Owner Jul 08, 2020 Buy $13.21 25,000 330,177 6,956,685 Jul 09, 2020, 02:40 PM
BIOTECH TARGET N V 10% Owner Apr 30, 2020 Buy $15.75 50,000 787,555 6,931,685 May 04, 2020, 05:32 PM
Kelly Joseph Francis Sr. VP of Sales and Marketing Feb 26, 2020 Sale $17.93 889 15,942 24,111 Feb 28, 2020, 04:15 PM
Hughes Owen Director Feb 26, 2020 Sale $17.95 2,750 49,363 10,650 Feb 28, 2020, 04:15 PM
Morris Charles Q Chief Medical Officer Feb 26, 2020 Sale $17.93 1,256 22,524 33,744 Feb 28, 2020, 04:15 PM
Rosenberg Anthony Director Feb 26, 2020 Sale $17.95 1,815 32,579 12,401 Feb 28, 2020, 04:15 PM
Dere Willard H Director Feb 26, 2020 Sale $17.95 1,925 34,554 12,195 Feb 28, 2020, 04:15 PM
Carmona Jose Chief Financial Officer Feb 26, 2020 Sale $17.93 1,292 23,169 46,708 Feb 28, 2020, 04:15 PM
BIOTECH GROWTH N V 10% Owner Nov 06, 2019 Buy $23.00 100,000 2,300,300 6,881,685 Nov 08, 2019, 02:52 PM
Rosenberg Anthony Director Jul 01, 2019 Sale $24.60 1,584 38,966 8,716 Jul 03, 2019, 04:02 PM
Kelly Joseph Francis Sr. VP of Sales and Marketing Jun 07, 2019 Buy $21.81 2,500 54,536 7,500 Jun 11, 2019, 06:40 AM
Kelly Joseph Francis Sr. VP of Sales and Marketing May 10, 2019 Buy $21.43 2,000 42,860 5,000 May 13, 2019, 05:17 PM
Hughes Owen Director Apr 16, 2019 Sale $22.22 2,400 53,328 7,900 Apr 18, 2019, 04:47 PM
Graves Kurt Director Apr 16, 2019 Sale $22.32 4,800 107,136 5,500 Apr 18, 2019, 04:44 PM
Dere Willard H Director Apr 16, 2019 Sale $22.22 1,680 37,330 8,620 Apr 18, 2019, 04:41 PM
Roychowdhury Debasish Director Apr 11, 2019 Sale $22.15 4,800 106,320 5,500 Apr 12, 2019, 04:14 PM
Hopfield Jessica Director Mar 05, 2019 Buy $19.23 12,800 246,190 12,800 Mar 06, 2019, 04:29 PM
BIOTECH GROWTH N V 10% Owner Feb 14, 2019 Option Exercise $14.00 71,409 1,000,012 6,781,685 Feb 19, 2019, 11:04 AM
BIOTECH GROWTH N V 10% Owner Dec 20, 2018 Buy $14.48 60,000 868,782 6,710,276 Dec 21, 2018, 12:00 PM
Kelly Joseph Francis Sr. VP of Sales and Marketing Dec 17, 2018 Buy $15.71 3,000 47,130 3,000 Dec 18, 2018, 08:34 AM
BIOTECH GROWTH N V 10% Owner Dec 14, 2018 Buy $15.64 60,000 938,256 6,650,276 Dec 17, 2018, 03:35 PM
BIOTECH GROWTH N V 10% Owner Aug 20, 2018 Buy $19.65 60,000 1,178,808 6,590,276 Aug 22, 2018, 11:08 AM
BIOTECH GROWTH N V 10% Owner Aug 14, 2018 Buy $20.87 100,000 2,086,880 6,460,913 Aug 16, 2018, 03:18 PM
BIOTECH GROWTH N V 10% Owner Aug 15, 2018 Buy $20.78 69,363 1,441,530 6,530,276 Aug 16, 2018, 03:18 PM
BIOTECH GROWTH N V 10% Owner Aug 08, 2018 Buy $22.73 60,000 1,363,884 6,360,913 Aug 10, 2018, 03:04 PM
BIOTECH GROWTH N V 10% Owner Jul 27, 2018 Buy $24.81 50,000 1,240,605 6,300,913 Jul 30, 2018, 05:23 PM
BIOTECH GROWTH N V 10% Owner Jul 25, 2018 Buy $27.28 50,000 1,363,805 6,250,913 Jul 26, 2018, 02:56 PM
BIOTECH GROWTH N V 10% Owner Jun 11, 2018 Buy $27.36 50,000 1,367,835 6,200,913 Jun 13, 2018, 03:29 PM
BIOTECH GROWTH N V 10% Owner May 23, 2018 Buy $28.91 40,000 1,156,320 6,150,913 May 24, 2018, 02:29 PM
BIOTECH GROWTH N V 10% Owner May 21, 2018 Buy $29.27 60,000 1,756,380 6,110,913 May 23, 2018, 02:42 PM
BIOTECH GROWTH N V 10% Owner Apr 19, 2018 Buy $33.80 40,000 1,351,936 6,050,913 Apr 23, 2018, 01:28 PM
BIOTECH GROWTH N V 10% Owner Apr 12, 2018 Option Exercise $14.00 107,114 1,500,024 6,010,913 Apr 16, 2018, 02:07 PM
BIOTECH GROWTH N V 10% Owner Apr 05, 2018 Buy $36.58 50,000 1,828,845 5,903,799 Apr 09, 2018, 01:19 PM
BIOTECH GROWTH N V 10% Owner Mar 02, 2018 Buy $32.52 80,000 2,601,448 5,853,799 Mar 06, 2018, 04:23 PM
BIOTECH GROWTH N V 10% Owner Feb 09, 2018 Buy $34.38 75,000 2,578,762 5,773,799 Feb 12, 2018, 04:54 PM
BIOTECH GROWTH N V 10% Owner Nov 14, 2017 Buy $26.25 50,000 1,312,390 5,698,799 Nov 16, 2017, 12:16 PM
Hatzis-Schoch Brent Sr. VP, General Counsel Nov 10, 2017 Buy $28.09 1,778 49,943 2,278 Nov 13, 2017, 07:26 AM
Hoiland Jesper President and CEO Nov 07, 2017 Buy $29.04 6,800 197,450 12,900 Nov 07, 2017, 05:14 PM
BIOTECH GROWTH N V 10% Owner Nov 03, 2017 Buy $29.15 50,000 1,457,575 5,648,799 Nov 07, 2017, 12:44 PM
BIOTECH GROWTH N V 10% Owner Oct 26, 2017 Buy $30.95 50,000 1,547,550 5,598,799 Oct 27, 2017, 03:39 PM
BIOTECH GROWTH N V 10% Owner Oct 25, 2017 Buy $32.85 50,000 1,642,415 5,548,799 Oct 26, 2017, 06:30 PM
BIOTECH GROWTH N V 10% Owner Sep 14, 2017 Buy $32.94 50,000 1,647,225 5,498,799 Sep 15, 2017, 02:05 PM
BIOTECH GROWTH N V 10% Owner Sep 13, 2017 Buy $33.71 100,000 3,370,750 5,448,799 Sep 15, 2017, 02:05 PM
Carmona Jose Chief Financial Officer Sep 14, 2017 Buy $32.83 3,000 98,503 3,000 Sep 15, 2017, 01:14 PM
Hoiland Jesper President and CEO Sep 15, 2017 Buy $32.72 6,100 199,608 6,100 Sep 15, 2017, 01:13 PM
BIOTECH GROWTH N V 10% Owner Sep 12, 2017 Buy $35.42 50,000 1,770,820 5,348,799 Sep 13, 2017, 03:49 PM
BIOTECH GROWTH N V 10% Owner Sep 05, 2017 Buy $36.75 50,000 1,837,625 5,298,799 Sep 07, 2017, 01:58 PM
BIOTECH GROWTH N V 10% Owner Aug 16, 2017 Buy $35.98 60,000 2,158,536 5,248,799 Aug 18, 2017, 11:41 AM
BIOTECH GROWTH N V 10% Owner Aug 10, 2017 Buy $34.26 75,000 2,569,500 5,188,799 Aug 11, 2017, 11:15 AM
BIOTECH GROWTH N V 10% Owner Aug 09, 2017 Buy $35.67 75,000 2,675,527 5,113,799 Aug 11, 2017, 11:15 AM
BIOTECH GROWTH N V 10% Owner May 30, 2017 Buy $34.21 40,000 1,368,348 5,038,799 May 31, 2017, 03:59 PM
BIOTECH GROWTH N V 10% Owner May 25, 2017 Buy $36.25 40,000 1,450,020 4,998,799 May 30, 2017, 02:00 PM
BIOTECH GROWTH N V 10% Owner May 18, 2017 Buy $34.41 50,000 1,720,345 4,958,799 May 22, 2017, 02:51 PM
BIOTECH GROWTH N V 10% Owner May 17, 2017 Buy $32.98 18,000 593,662 4,908,799 May 18, 2017, 11:21 AM
BIOTECH GROWTH N V 10% Owner May 16, 2017 Buy $33.92 17,000 576,725 4,890,799 May 18, 2017, 11:21 AM
BIOTECH GROWTH N V 10% Owner May 12, 2017 Buy $34.00 15,000 509,995 4,873,799 May 16, 2017, 11:41 AM
BIOTECH GROWTH N V 10% Owner May 09, 2017 Buy $35.93 50,000 1,796,480 4,858,799 May 11, 2017, 02:51 PM
BIOTECH GROWTH N V 10% Owner May 08, 2017 Buy $35.60 22,800 811,630 4,808,799 May 09, 2017, 01:05 PM
BIOTECH GROWTH N V 10% Owner May 05, 2017 Buy $35.55 20,600 732,283 4,785,999 May 09, 2017, 01:05 PM
BIOTECH GROWTH N V 10% Owner May 02, 2017 Buy $33.91 75,000 2,542,920 4,765,399 May 03, 2017, 03:12 PM
BIOTECH GROWTH N V 10% Owner May 01, 2017 Buy $35.39 150,000 5,308,605 4,690,399 May 02, 2017, 01:37 PM
Harvey Brian Nicholas Sr. VP and CFO Apr 25, 2017 Option Exercise $2.74 39,616 108,548 76,189 Apr 27, 2017, 08:58 PM
BIOTECH GROWTH N V 10% Owner Mar 21, 2017 Buy $35.83 50,000 1,791,625 4,540,399 Mar 22, 2017, 05:28 PM
Harvey Brian Nicholas Sr. VP and CFO Mar 20, 2017 Option Exercise $2.05 23,416 48,003 36,573 Mar 22, 2017, 04:44 PM
BIOTECH GROWTH N V 10% Owner Mar 17, 2017 Buy $38.41 30,000 1,152,249 4,490,399 Mar 21, 2017, 12:31 PM
BIOTECH GROWTH N V 10% Owner Mar 14, 2017 Buy $40.00 17,252 690,068 4,415,930 Mar 16, 2017, 04:42 PM
BIOTECH GROWTH N V 10% Owner Mar 15, 2017 Buy $39.96 44,469 1,776,803 4,460,399 Mar 16, 2017, 04:42 PM
BIOTECH GROWTH N V 10% Owner Mar 10, 2017 Buy $39.17 38,279 1,499,285 4,398,678 Mar 14, 2017, 01:29 PM
Ward Robert President & CEO Oct 25, 2016 Option Exercise $7.80 10,000 78,000 15,000 Oct 25, 2016, 09:54 PM
Fitzpatrick Lorraine A. Chief Medical Officer Nov 25, 2015 Buy $60.60 100 6,060 100 Jan 26, 2016, 09:00 PM
Fitzpatrick Lorraine A. Chief Medical Officer Jan 25, 2016 Buy $37.97 100 3,797 200 Jan 26, 2016, 09:00 PM
BIOTECH GROWTH N V 10% Owner Jan 22, 2016 Buy $31.67 38,259 1,211,502 4,360,399 Jan 25, 2016, 03:51 PM
BIOTECH GROWTH N V 10% Owner Jan 13, 2016 Buy $39.90 50,000 1,994,885 4,322,140 Jan 14, 2016, 05:44 PM
Ward Robert President & CEO Nov 23, 2015 Option Exercise $7.80 25,000 195,000 25,000 Nov 25, 2015, 09:45 PM
Ward Robert President & CEO Nov 23, 2015 Sale $62.76 25,000 1,569,125 0 Nov 25, 2015, 09:45 PM
Hattersley Gary Chief Scientific Officer Nov 12, 2015 Option Exercise $2.74 5,683 15,571 0 Nov 13, 2015, 09:45 PM
Hattersley Gary Chief Scientific Officer Nov 12, 2015 Sale $75.00 5,683 426,225 0 Nov 13, 2015, 09:45 PM
Hattersley Gary Chief Scientific Officer Nov 03, 2015 Option Exercise $2.74 13,333 36,532 0 Nov 05, 2015, 09:47 PM
Hattersley Gary Chief Scientific Officer Nov 03, 2015 Sale $70.00 13,333 933,310 0 Nov 05, 2015, 09:47 PM
Hattersley Gary Chief Scientific Officer Oct 23, 2015 Option Exercise $2.16 11,302 24,366 10,428 Oct 27, 2015, 09:47 PM
Hattersley Gary Chief Scientific Officer Oct 23, 2015 Sale $65.00 11,302 734,630 0 Oct 27, 2015, 09:47 PM
Hattersley Gary Chief Scientific Officer Oct 21, 2015 Option Exercise $3.42 1,501 5,133 1,501 Oct 23, 2015, 09:45 PM
Ward Rob President & CEO Oct 21, 2015 Option Exercise $7.80 50,000 390,000 50,000 Oct 23, 2015, 09:45 PM
Hattersley Gary Chief Scientific Officer Oct 21, 2015 Sale $65.36 1,501 98,105 0 Oct 23, 2015, 09:45 PM
Ward Rob President & CEO Oct 21, 2015 Sale $61.99 50,000 3,099,500 0 Oct 23, 2015, 09:45 PM
Snow David P. Chief Commercial Officer Sep 14, 2015 Buy $69.79 6,000 418,740 6,000 Sep 28, 2015, 09:14 PM
Purandare Dinesh SVP Global Oncology/Commercial Aug 31, 2015 Buy $62.20 200 12,440 200 Sep 08, 2015, 08:35 PM
BIOTECH GROWTH N V 10% Owner Aug 21, 2015 Buy $63.45 50,000 3,172,270 4,272,140 Aug 24, 2015, 03:31 PM
BIOTECH GROWTH N V 10% Owner Aug 20, 2015 Buy $64.56 50,000 3,227,760 4,222,140 Aug 24, 2015, 03:31 PM
Graves Kurt Director Aug 17, 2015 Option Exercise $7.34 22,694 166,574 22,694 Aug 19, 2015, 07:30 PM
Graves Kurt Director Aug 17, 2015 Sale $70.00 22,694 1,588,580 0 Aug 19, 2015, 07:30 PM
Graves Kurt Director Aug 10, 2015 Option Exercise $7.34 2,306 16,926 2,306 Aug 12, 2015, 05:26 PM
Graves Kurt Director Aug 10, 2015 Sale $70.00 2,306 161,420 0 Aug 12, 2015, 05:26 PM
BIOTECH GROWTH N V 10% Owner Jul 23, 2015 Buy $74.00 250,000 18,500,000 4,172,140 Jul 27, 2015, 06:20 PM
Graves Kurt Director Jul 06, 2015 Option Exercise $7.34 25,000 183,500 25,000 Jul 08, 2015, 03:04 PM
Graves Kurt Director Jul 06, 2015 Sale $69.48 25,000 1,736,908 0 Jul 08, 2015, 03:04 PM
Graves Kurt Director Jun 18, 2015 Option Exercise $7.34 25,000 183,500 25,000 Jun 22, 2015, 05:57 PM
Graves Kurt Director Jun 18, 2015 Sale $55.05 25,000 1,376,250 0 Jun 22, 2015, 05:57 PM
Ward Robert President and CEO Jun 04, 2015 Option Exercise $7.80 5,000 39,000 5,000 Jun 05, 2015, 07:18 PM
BIOTECH GROWTH N V 10% Owner May 01, 2015 Buy $36.46 50,000 1,822,965 3,922,140 May 04, 2015, 04:46 PM
BIOTECH GROWTH N V 10% Owner Apr 29, 2015 Buy $36.23 50,000 1,811,580 3,872,140 Apr 30, 2015, 11:55 AM
BIOTECH GROWTH N V 10% Owner Apr 28, 2015 Buy $36.59 50,000 1,829,275 3,822,140 Apr 29, 2015, 02:50 PM
BIOTECH GROWTH N V 10% Owner Apr 27, 2015 Buy $38.38 50,000 1,919,010 3,772,140 Apr 29, 2015, 02:50 PM
BIOTECH GROWTH N V 10% Owner Mar 06, 2015 Buy $47.08 75,000 3,531,127 3,722,140 Mar 09, 2015, 04:35 PM
BIOTECH GROWTH N V 10% Owner Feb 25, 2015 Buy $45.74 35,000 1,600,851 3,647,140 Feb 27, 2015, 12:08 PM
F2 Bioscience IV L.P. 10% Owner Jun 11, 2014 Buy $8.00 587,500 4,700,000 587,500 Jun 13, 2014, 04:16 PM
Jovan-Embiricos Morana Director Jun 11, 2014 Buy $8.00 587,500 4,700,000 587,500 Jun 13, 2014, 10:13 AM
BIOTECH GROWTH N V 10% Owner Jun 06, 2014 Buy $8.00 1,000,000 8,000,000 2,705,040 Jun 12, 2014, 05:07 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
BIOTECH TARGET N V 10% Owner 08/11/2022 87,335,380
SANDERS MACHELLE Director 08/15/2022 55,000
Hughes Owen Director 08/15/2022 216,500
Shah Chhaya Chief Business Officer 08/15/2022 946,450
FRIEDMAN CATHY Director 08/15/2022 268,000
Dere Willard H Director 08/15/2022 18,950
Dere Willard H Director 08/15/2022 213,000
GARNIER JEAN PIERRE Director 08/15/2022 55,000
GARNIER JEAN PIERRE Director 08/15/2022 268,000
VON ESCHENBACH ANDREW C. Director 08/15/2022 55,000
Holtschlag Danielle Vice President, Sales 08/15/2022 250,000
Messersmith Elizabeth Senior Vice President 08/15/2022 700,000
Murphy Sean Director 08/15/2022 55,000
Martin G. Kelly CEO and President 08/15/2022 750,000
Rubric Capital Management LP 10% Owner 08/11/2022 16,907,066
Rubric Capital Management LP 10% Owner 08/10/2022 40,401
BIOTECH TARGET N V 10% Owner 05/18/2022 2,661,002
BIOTECH TARGET N V 10% Owner 01/06/2022 1,894,410
BIOTECH TARGET N V 10% Owner 01/05/2022 1,574,650
Rubric Capital Management LP 10% Owner 12/16/2021 1,037,752
Rubric Capital Management LP 10% Owner 12/15/2021 1,223,637
Rubric Capital Management LP 10% Owner 12/14/2021 640,936
Rubric Capital Management LP 10% Owner 12/13/2021 1,326,803
Rubric Capital Management LP 10% Owner 12/09/2021 2,007,086
Rubric Capital Management LP 10% Owner 12/08/2021 4,497,078
Rubric Capital Management LP 10% Owner 12/10/2021 5,511,627
BIOTECH TARGET N V 10% Owner 09/29/2021 1,294,500
BIOTECH TARGET N V 10% Owner 09/22/2021 1,841,280
Chopas James George Principal Finance Accounting 03/05/2021 7,726
Grausso Sal Chief Commercial Officer 02/25/2021 25,025
BIOTECH TARGET N V 10% Owner 11/05/2020 1,426,230
BIOTECH TARGET N V 10% Owner 09/14/2020 2,338,680
BIOTECH TARGET N V 10% Owner 09/11/2020 2,255,118
BIOTECH TARGET N V 10% Owner 07/08/2020 330,177
BIOTECH TARGET N V 10% Owner 04/30/2020 787,555
Kelly Joseph Francis Sr. VP of Sales and Marketing 02/26/2020 15,942
Hughes Owen Director 02/26/2020 49,363
Morris Charles Q Chief Medical Officer 02/26/2020 22,524
Rosenberg Anthony Director 02/26/2020 32,579
Dere Willard H Director 02/26/2020 34,554
Carmona Jose Chief Financial Officer 02/26/2020 23,169
BIOTECH GROWTH N V 10% Owner 11/06/2019 2,300,300
Rosenberg Anthony Director 07/01/2019 38,966
Kelly Joseph Francis Sr. VP of Sales and Marketing 06/07/2019 54,536
Kelly Joseph Francis Sr. VP of Sales and Marketing 05/10/2019 42,860
Hughes Owen Director 04/16/2019 53,328
Graves Kurt Director 04/16/2019 107,136
Dere Willard H Director 04/16/2019 37,330
Roychowdhury Debasish Director 04/11/2019 106,320
Hopfield Jessica Director 03/05/2019 246,190
BIOTECH GROWTH N V 10% Owner 02/14/2019 1,000,012
BIOTECH GROWTH N V 10% Owner 12/20/2018 868,782
Kelly Joseph Francis Sr. VP of Sales and Marketing 12/17/2018 47,130
BIOTECH GROWTH N V 10% Owner 12/14/2018 938,256
BIOTECH GROWTH N V 10% Owner 08/20/2018 1,178,808
BIOTECH GROWTH N V 10% Owner 08/14/2018 2,086,880
BIOTECH GROWTH N V 10% Owner 08/15/2018 1,441,530
BIOTECH GROWTH N V 10% Owner 08/08/2018 1,363,884
BIOTECH GROWTH N V 10% Owner 07/27/2018 1,240,605
BIOTECH GROWTH N V 10% Owner 07/25/2018 1,363,805
BIOTECH GROWTH N V 10% Owner 06/11/2018 1,367,835
BIOTECH GROWTH N V 10% Owner 05/23/2018 1,156,320
BIOTECH GROWTH N V 10% Owner 05/21/2018 1,756,380
BIOTECH GROWTH N V 10% Owner 04/19/2018 1,351,936
BIOTECH GROWTH N V 10% Owner 04/12/2018 1,500,024
BIOTECH GROWTH N V 10% Owner 04/05/2018 1,828,845
BIOTECH GROWTH N V 10% Owner 03/02/2018 2,601,448
BIOTECH GROWTH N V 10% Owner 02/09/2018 2,578,762
BIOTECH GROWTH N V 10% Owner 11/14/2017 1,312,390
Hatzis-Schoch Brent Sr. VP, General Counsel 11/10/2017 49,943
Hoiland Jesper President and CEO 11/07/2017 197,450
BIOTECH GROWTH N V 10% Owner 11/03/2017 1,457,575
BIOTECH GROWTH N V 10% Owner 10/26/2017 1,547,550
BIOTECH GROWTH N V 10% Owner 10/25/2017 1,642,415
BIOTECH GROWTH N V 10% Owner 09/14/2017 1,647,225
BIOTECH GROWTH N V 10% Owner 09/13/2017 3,370,750
Carmona Jose Chief Financial Officer 09/14/2017 98,503
Hoiland Jesper President and CEO 09/15/2017 199,608
BIOTECH GROWTH N V 10% Owner 09/12/2017 1,770,820
BIOTECH GROWTH N V 10% Owner 09/05/2017 1,837,625
BIOTECH GROWTH N V 10% Owner 08/16/2017 2,158,536
BIOTECH GROWTH N V 10% Owner 08/10/2017 2,569,500
BIOTECH GROWTH N V 10% Owner 08/09/2017 2,675,527
BIOTECH GROWTH N V 10% Owner 05/30/2017 1,368,348
BIOTECH GROWTH N V 10% Owner 05/25/2017 1,450,020
BIOTECH GROWTH N V 10% Owner 05/18/2017 1,720,345
BIOTECH GROWTH N V 10% Owner 05/17/2017 593,662
BIOTECH GROWTH N V 10% Owner 05/16/2017 576,725
BIOTECH GROWTH N V 10% Owner 05/12/2017 509,995
BIOTECH GROWTH N V 10% Owner 05/09/2017 1,796,480
BIOTECH GROWTH N V 10% Owner 05/08/2017 811,630
BIOTECH GROWTH N V 10% Owner 05/05/2017 732,283
BIOTECH GROWTH N V 10% Owner 05/02/2017 2,542,920
BIOTECH GROWTH N V 10% Owner 05/01/2017 5,308,605
Harvey Brian Nicholas Sr. VP and CFO 04/25/2017 108,548
BIOTECH GROWTH N V 10% Owner 03/21/2017 1,791,625
Harvey Brian Nicholas Sr. VP and CFO 03/20/2017 48,003
BIOTECH GROWTH N V 10% Owner 03/17/2017 1,152,249
BIOTECH GROWTH N V 10% Owner 03/14/2017 690,068
BIOTECH GROWTH N V 10% Owner 03/15/2017 1,776,803
BIOTECH GROWTH N V 10% Owner 03/10/2017 1,499,285
Ward Robert President & CEO 10/25/2016 78,000
Fitzpatrick Lorraine A. Chief Medical Officer 11/25/2015 6,060
Fitzpatrick Lorraine A. Chief Medical Officer 01/25/2016 3,797
BIOTECH GROWTH N V 10% Owner 01/22/2016 1,211,502
BIOTECH GROWTH N V 10% Owner 01/13/2016 1,994,885
Ward Robert President & CEO 11/23/2015 195,000
Ward Robert President & CEO 11/23/2015 1,569,125
Hattersley Gary Chief Scientific Officer 11/12/2015 15,571
Hattersley Gary Chief Scientific Officer 11/12/2015 426,225
Hattersley Gary Chief Scientific Officer 11/03/2015 36,532
Hattersley Gary Chief Scientific Officer 11/03/2015 933,310
Hattersley Gary Chief Scientific Officer 10/23/2015 24,366
Hattersley Gary Chief Scientific Officer 10/23/2015 734,630
Hattersley Gary Chief Scientific Officer 10/21/2015 5,133
Ward Rob President & CEO 10/21/2015 390,000
Hattersley Gary Chief Scientific Officer 10/21/2015 98,105
Ward Rob President & CEO 10/21/2015 3,099,500
Snow David P. Chief Commercial Officer 09/14/2015 418,740
Purandare Dinesh SVP Global Oncology/Commercial 08/31/2015 12,440
BIOTECH GROWTH N V 10% Owner 08/21/2015 3,172,270
BIOTECH GROWTH N V 10% Owner 08/20/2015 3,227,760
Graves Kurt Director 08/17/2015 166,574
Graves Kurt Director 08/17/2015 1,588,580
Graves Kurt Director 08/10/2015 16,926
Graves Kurt Director 08/10/2015 161,420
BIOTECH GROWTH N V 10% Owner 07/23/2015 18,500,000
Graves Kurt Director 07/06/2015 183,500
Graves Kurt Director 07/06/2015 1,736,908
Graves Kurt Director 06/18/2015 183,500
Graves Kurt Director 06/18/2015 1,376,250
Ward Robert President and CEO 06/04/2015 39,000
BIOTECH GROWTH N V 10% Owner 05/01/2015 1,822,965
BIOTECH GROWTH N V 10% Owner 04/29/2015 1,811,580
BIOTECH GROWTH N V 10% Owner 04/28/2015 1,829,275
BIOTECH GROWTH N V 10% Owner 04/27/2015 1,919,010
BIOTECH GROWTH N V 10% Owner 03/06/2015 3,531,127
BIOTECH GROWTH N V 10% Owner 02/25/2015 1,600,851
F2 Bioscience IV L.P. 10% Owner 06/11/2014 4,700,000
Jovan-Embiricos Morana Director 06/11/2014 4,700,000
BIOTECH GROWTH N V 10% Owner 06/06/2014 8,000,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2022
03/31/2022
0.16%
1Q
06/30/2022
09/30/2021
0.73%
3Q
06/30/2022
06/30/2021
0.85%
4Q
06/30/2022
03/31/2021
1.14%
5Q
06/30/2022
12/31/2020
2.27%
6Q
06/30/2022
09/30/2020
2.41%
7Q
06/30/2022
06/30/2020
2.52%
8Q
06/30/2022
03/31/2020
2.69%
9Q
06/30/2022
12/31/2019
3.24%
10Q
06/30/2022
09/30/2019
3.35%
11Q
06/30/2022
06/30/2019
3.54%
12Q
06/30/2022
03/31/2019
4.04%
13Q
06/30/2022
09/30/2018
4.91%
15Q
06/30/2022
06/30/2018
5.16%
16Q
Load More

Period of Report: 06/30/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2022
0.16%
1Q
09/30/2021
0.73%
3Q
06/30/2021
0.85%
4Q
03/31/2021
1.14%
5Q
12/31/2020
2.27%
6Q
09/30/2020
2.41%
7Q
06/30/2020
2.52%
8Q
03/31/2020
2.69%
9Q
12/31/2019
3.24%
10Q
09/30/2019
3.35%
11Q
06/30/2019
3.54%
12Q
03/31/2019
4.04%
13Q
09/30/2018
4.91%
15Q
06/30/2018
5.16%
16Q
Load More